Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ratko Djukanovic

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
The European Respiratory Journal|December 23, 2018
"T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostinStelios Pavlidis, Kentaro Takahashi, Francois Ng Kee Kwong, et al.
The European Respiratory Journal|November 2, 2016
Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED studySusan J Wilson, Jonathan A Ward, Ana R Sousa, et al.
ERJ Open Research|May 5, 2023
Characteristics of severe asthma patients on biologics: a real-life European registry studyStefania Principe, Levi B Richards, Simone Hashimoto, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2016
A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPREDChih-Hsi Scott Kuo, Stelios Pavlidis, Matthew Loza, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2022
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation PhenotypesP Jane McDowell, John Busby, Catherine E Hanratty, et al.
The European Respiratory Journal|September 25, 2021
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthmaJohn Busby, John G Matthews, Rekha Chaudhuri, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 9, 2023
A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by SexMatthew C Eastwood, John Busby, David J Jackson, et al.
Nature Genetics|January 12, 2021
A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infectionCornelia Blume, Claire L Jackson, Cosma Mirella Spalluto, et al.
The Journal of Allergy and Clinical Immunology. Global|July 18, 2025
Chromosome 21 variants tied to severe asthma exacerbations: A genome-wide association study in a Brazilian populationMaria B R de Santana, Álvaro A Cruz, Helena M P Teixeira, et al.
Trials|January 6, 2018
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trialCatherine E Hanratty, John G Matthews, Joseph R Arron, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
The European Respiratory Journal|December 23, 2018
"T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostinStelios Pavlidis, Kentaro Takahashi, Francois Ng Kee Kwong, et al.
The European Respiratory Journal|November 2, 2016
Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED studySusan J Wilson, Jonathan A Ward, Ana R Sousa, et al.
ERJ Open Research|May 5, 2023
Characteristics of severe asthma patients on biologics: a real-life European registry studyStefania Principe, Levi B Richards, Simone Hashimoto, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2016
A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPREDChih-Hsi Scott Kuo, Stelios Pavlidis, Matthew Loza, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2022
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation PhenotypesP Jane McDowell, John Busby, Catherine E Hanratty, et al.
The European Respiratory Journal|September 25, 2021
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthmaJohn Busby, John G Matthews, Rekha Chaudhuri, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 9, 2023
A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by SexMatthew C Eastwood, John Busby, David J Jackson, et al.
Nature Genetics|January 12, 2021
A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infectionCornelia Blume, Claire L Jackson, Cosma Mirella Spalluto, et al.
The Journal of Allergy and Clinical Immunology. Global|July 18, 2025
Chromosome 21 variants tied to severe asthma exacerbations: A genome-wide association study in a Brazilian populationMaria B R de Santana, Álvaro A Cruz, Helena M P Teixeira, et al.
Trials|January 6, 2018
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trialCatherine E Hanratty, John G Matthews, Joseph R Arron, et al.
Pageof 13